Cargando…

Preferential Production of Interleukin‐1β over Interleukin‐1 Receptor Antagonist Contributes to Proliferation and Suppression of Apoptosis in Leukemic Cells

Normal human monocytes were isolated in a nascent state by centrifugal elutriation and used for the study of interleukin‐1 (IL‐1) and interleukin‐1 receptor antagonist (IL‐1ra) expression. Neither IL‐1β nor IL‐1ra mRNA was present in monocytes just after the isolation, but they were induced simultan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furukawa, Yusuke, Kikuchi, Jiro, Terui, Yasuhito, Kitagawa, Seiichi, Ohta, Masatsugu, Miura, Yasusada, Saito, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1995
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920749/ https://www.ncbi.nlm.nih.gov/pubmed/7730146 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03041.x

Ejemplares similares

Clinical Application of Phorbol Diester‐induced Leukemic Cell Differentiation for the Definite Diagnosis of Acute Leukemias
por: Ohta, Masatsugu, et al.
Publicado: (1988)

Interleukin 1-β, Interleukin-1 Receptor Antagonist, and Interleukin 18 in Children with Acute Spontaneous Urticaria
por: Machura, E., et al.
Publicado: (2013)

The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse
por: Bjrök, P., et al.
Publicado: (1992)

Interleukin Expression after Injury and the Effects of Interleukin-1 Receptor Antagonist
por: Chamberlain, Connie S., et al.
Publicado: (2013)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Physiologic role of interleukin-1 receptor antagonist
por: Arend, William P, et al.
Publicado: (2000)

Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis
por: Abadie, Bryan Q., et al.
Publicado: (2022)

AMP‐activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR‐ABL protein in CML cells
por: Koyama, Daisuke, et al.
Publicado: (2020)

Interleukin 1-β, interleukin-1 receptor antagonist and vitamin D levels in children with atopic dermatitis
por: Machura, Edyta, et al.
Publicado: (2018)

Role of interleukin-25 in development of spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice
por: Abe, Yasuharu, et al.
Publicado: (2017)

Interleukin 2-induced proliferation of leukemic human B cells
Publicado: (1985)

Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
por: Hui, Queenie, et al.
Publicado: (2017)

Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy
por: Liao, Xueling, et al.
Publicado: (2022)

Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression
por: Goto, Hisashi, et al.
Publicado: (2015)

Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse
por: Abbate, Antonio, et al.
Publicado: (2011)

Production of interleukin-1 receptor antagonist by human articular chondrocytes
por: Palmer, Gaby, et al.
Publicado: (2002)

Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes
por: Vecile, Elena, et al.
Publicado: (2013)

Interleukin-1 Receptor Antagonist Isoforms in Collagen-Induced Arthritis
por: Gabay, Cem, et al.
Publicado: (2000)

Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
por: Gong, Zhenqiang, et al.
Publicado: (2018)

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
por: Fan, Yu-Ching, et al.
Publicado: (2020)

Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
por: Lindblad, Caroline, et al.
Publicado: (2023)

Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells
Publicado: (1985)

Correction: Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression
por: Goto, Hisashi, et al.
Publicado: (2020)

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
por: Lewis, Anne M, et al.
Publicado: (2006)

Association between Polymorphism of Interleukin-1beta and Interleukin-1 Receptor Antagonist Gene and Asthma Risk: A Meta-Analysis
por: He, Yuanzhou, et al.
Publicado: (2015)

Interleukin-1β and interleukin-1receptor antagonist polymorphisms in Egyptian children with febrile seizures: A case-control study
por: Al Morshedy, Salah, et al.
Publicado: (2017)

Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer
por: Armbruster, Nicole, et al.
Publicado: (2017)

Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist
Publicado: (1995)

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
por: Lindmark, F, et al.
Publicado: (2005)

Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
por: Nicklin, Martin J.H., et al.
Publicado: (2000)

Production of interleukin (IL)-1 receptor antagonist by human articular chondrocytes
por: Palmer, G, et al.
Publicado: (2002)

Safety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19
por: Dimosiari, Athina, et al.
Publicado: (2023)

Interleukin-1 Receptor Antagonist and Interleukin-4 Genes Variable Number Tandem Repeats Are Associated with Adiposity in Malaysian Subjects
por: Kok, Yung-Yean, et al.
Publicado: (2017)

Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
por: Tadić, André, et al.
Publicado: (2008)

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells
Publicado: (1993)

Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis
por: Prins, Marloes, et al.
Publicado: (2013)

Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta
por: Deng, Rong-Hui, et al.
Publicado: (2018)

The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release
por: Smith, G. S., et al.
Publicado: (1996)

Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
por: Larsen, Claus M., et al.
Publicado: (2009)

Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion
por: Liu, Mengyuan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l8iankpc3jil9c3fqge2blq40r